The biologics safety testing market was valued at USD 4.08 billion in 2023 and is projected to reach USD 11.18 billion by 2031, growing at a CAGR of 13.4%. This growth is fueled by rising biopharmaceutical demand, strict regulatory requirements, increased R&D investments, advancements in testing technologies, and a trend toward outsourcing services.
Uploaded 6 months ago
Direct links
Image link
Image URL
Full image (linked)
Website (HTML)
Forums (BBCode)
Share image
Image information:
The biologics safety testing market was valued at USD 4.08 billion in 2023 and is projected to reach USD 11.18 billion by 2031, growing at a CAGR of 13.4%. This growth is fueled by rising biopharmaceutical demand, strict regulatory requirements, increased R&D investments, advancements in testing technologies, and a trend toward outsourcing services.